ARTICLE | Company News
Biolucidation LLC, Melior deal
July 15, 2013 7:00 AM UTC
Melior acquired all assets of CRO Biolucidation, which specialized in drug abuse liability studies. Melior said the acquisition significantly expands its preclinical pharmacology capabilities. Melior ...